| Literature DB >> 9789907 |
K W Sax1, S M Strakowski, P E Keck.
Abstract
This study examined changes in attentional performance in patients with schizophrenia during the 2 months after initiating treatment with quetiapine fumarate. Prior to treatment, attentional performance in patients with schizophrenia (n = 10) was significantly (p < 0.01) worse than in matched controls (n = 12). During treatment with quetiapine, performance in patients with schizophrenia improved, and by 2 months, did not differ significantly from that of the controls. These results suggest that quetiapine produces a significant improvement in attentional functioning in patients with schizophrenia.Entities:
Mesh：
Substances：
Year: 1998 PMID： 9789907 DOI： 10.1016/s0920-9964(98)00067-x
Source DB: PubMed Journal: Schizophr Res ISSN： 0920-9964 Impact factor: 4.939